• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>DuPont Company

DuPont Company

PowerShares Dynamic Pharmaceuticals ETF PJP 5 Star

Last Price$60.98Day Change (%)-0.23%
Open Price$60.83Day Change ($)-0.14
Day Range60.47–61.0052-Week Range53.55–69.24

As of Sat 2/24/2017 9:00:00 PM | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. UPDATE: Chemours stock and bonds rally as DuPont splits settlement of toxic chemical suits

    UPDATE: Chemours stock and bonds rally as DuPont splits settlement of toxic chemical suits

  2. UPDATE: Chemours stock and bonds rally as DuPont splits settlement of toxic chemical suits

    UPDATE: Chemours stock and bonds rally as DuPont splits settlement of toxic chemical suits

  3. UPDATE: Chemours stock and bonds rally as DuPont splits settlement of toxic chemical suits

    UPDATE: Chemours stock and bonds rally as DuPont splits settlement of toxic chemical suits

  4. UPDATE: Chemours stock and bonds rally as DuPont splits settlement of toxic chemical suits

    UPDATE: Chemours stock and bonds rally as DuPont splits settlement of toxic chemical suits

  5. DuPont's stock surge helps push Dow industrials into positive territory

    DuPont's stock surge helps push Dow industrials into positive territory

  6. Dupont , Chemours settle Teflon chemical exposure case for $671 million

    Dupont , Chemours settle Teflon chemical exposure case for $671 million

  7. UPDATE: Chemours proves the bears wrong as stock climbs eightfold in a year

    UPDATE: Chemours proves the bears wrong as stock climbs eightfold in a year

  8. UPDATE: Chemours proves the bears wrong as stock climbs eightfold in a year

    UPDATE: Chemours proves the bears wrong as stock climbs eightfold in a year

  9. UPDATE: Chemours proves the bears wrong as stock climbs eightfold in a year

    UPDATE: Chemours proves the bears wrong as stock climbs eightfold in a year

  10. UPDATE: Chemours proves the bears wrong as stock climbs eightfold in a year

    UPDATE: Chemours proves the bears wrong as stock climbs eightfold in a year

12345

©2017 Morningstar Advisor. All right reserved.